Aclaris Therapeutics Inc (ACRS) earnings · rev $3.6M
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
This ACRS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
When the next ACRS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 81.6% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full ACRS research stays on the stock page; the tape stays on the quote page.
Not investment advice.